1351479-09-8 Usage
General Description
1H-Pyrrole-2-MethanaMine HCl, also known as N-methylpyrrolidine hydrochloride, is a chemical compound with the molecular formula C5H10N2?HCl. It is a white crystalline solid that is soluble in water and ethanol. 1H-Pyrrole-2-MethanaMine HCl is commonly used in organic synthesis and pharmaceutical research as a building block for the synthesis of various organic compounds. It can also be used as a catalyst or reagent in chemical reactions. Additionally, it has potential applications in the pharmaceutical industry for the development of new drugs. However, it is important to note that this compound should be handled and used with caution, as it can be hazardous if not properly handled.
Check Digit Verification of cas no
The CAS Registry Mumber 1351479-09-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,1,4,7 and 9 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1351479-09:
(9*1)+(8*3)+(7*5)+(6*1)+(5*4)+(4*7)+(3*9)+(2*0)+(1*9)=158
158 % 10 = 8
So 1351479-09-8 is a valid CAS Registry Number.
1351479-09-8Relevant articles and documents
Novel thiourea derivatives and the pharmaceutical compositions containing the same
-
, (2008/06/13)
The present invention relates to novel thiourca derivatives as a modulator for vanilloid receptor (VR) and the phar- maceutical compositions containing the same. As diseases associated with the activity of vanilloid receptor, pain acute pain, chronic pain, neuropathic pain, post-operative pain, migraine, arthralgia, neuropathies, nerve injury, diabetic neuropathy, neurodegeneration, neurotic skin disorder, stroke, urinary bladder hypersensitiveness, irritable bowel syndrome, a respiratory disorder such as asthma or chronic obstructive pulmonary disease, irritation of skin, eye or mucous membrane, fervescence, stomach-duodenal ulcer, inflam- matory bowel disease and inflammatory diseases can be enumerated. The present invention provides a pharmaceutical composition for prevention or treatment of these diseases.
